GSA CAPITAL PARTNERS LLP - SANA BIOTECHNOLOGY INC ownership

SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 122 filers reported holding SANA BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of SANA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$2,091
+140.9%
540,250
+103.6%
0.18%
+108.1%
Q1 2023$868
-33.0%
265,372
-19.0%
0.09%
-46.6%
Q4 2022$1,295
-99.9%
327,793
+66.4%
0.16%
+2.5%
Q3 2022$1,182,000
+92.8%
196,977
+106.7%
0.16%
+70.7%
Q2 2022$613,000
-45.5%
95,310
-30.0%
0.09%
-39.1%
Q1 2022$1,124,000136,1050.15%
Other shareholders
SANA BIOTECHNOLOGY INC shareholders Q2 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 34,239,018$282,814,0006.64%
Crestline Management, LP 3,210,937$26,522,0003.18%
Omega Fund Management, LLC 843,750$6,969,0001.43%
Alphabet Inc. 2,812,500$23,231,0000.75%
HARVARD MANAGEMENT CO INC 468,749$3,872,0000.39%
Woodline Partners LP 1,551,940$12,819,0000.21%
PUBLIC SECTOR PENSION INVESTMENT BOARD 4,131,249$34,124,0000.21%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 156,254$1,291,0000.19%
GSA CAPITAL PARTNERS LLP 136,105$1,124,0000.15%
Artal Group S.A. 400,000$3,304,0000.14%
View complete list of SANA BIOTECHNOLOGY INC shareholders